Curing patients with locally advanced esophageal cancer: An update on multimodality therapy

Diseases of the Esophagus

Volumn 19, Issue 6, 2006, Pages 448-453

  Mckian, K P ^a   Miller, R C ^a   Cassivi, S D ^a   Jatoi, Aminah ^a,b  

^a MAYO CLINIC   (United States)

^b NONE   (United States)

Author keywords

Chemotherapy; Esophageal cancer; Radiation; Surgery

Indexed keywords

CISPLATIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID;

ADVANCED CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; HUMAN; META ANALYSIS; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PATIENT CARE; PREOPERATIVE RADIOTHERAPY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; SURVIVAL RATE; SURVIVAL TIME; SYSTEMATIC REVIEW; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADENOCARCINOMA; CHEMOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; HUMANS; NEOADJUVANT THERAPY;

EID: 33750440525     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2006.00611.x     Document Type: Review

References (17)

1. Muller J M, Zieren U, Wolters U, Pichlmaier H. Results of esophagectomy and gastric bypass for cancer of the esophagus. Hepatogastroenterology 1989; 36: 522-8.
2. Hulscher J B, Tijssen J G, Obertop H, van Lanschot J J. Transthoracic versus transhiatal resection for carcinoma of the esophagus: A meta-analysis. Ann Thorac Surg 2001; 72: 306-13.
3. Hulscher J B, van Sandick J W, de Boer A G et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002; 347: 1662-9.
4. Eloubeidi M A, Wallace M B, Hoffman B J et al. Predictors of survival for esophageal cancer patients with and without celiac axis lymphadenectomy: Impact of staging and endosonography. Ann Thorac Surg 2001; 72: 212-20.
5. de Boer A G E M, van Lanschot J J B, van Sandick J W et al. Quality of life after transhiatal compared with extended transthoracic resection of adenocarcinoma of the esophagus. J Clin Oncol 2004; 22: 4202-8.
6. Walsh T N, Noonan N, Hollywood D et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 335: 462-7.
7. Kaklamanos I G, Walker G, Ferry K, Franceschi D, Livingstone A S. Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: A meta-analysis of randomized clinical trials. Ann Surg Oncol 2003; 10: 754-61.
8. Urschel J D, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2003; 185: 538-43.
9. Medical Research Council Oesophageal Cancer Working Party. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: A randomized controlled trial. Lancet 2002; 359: 1727-33.
10. Kelsen D P, Ginsberg R, Pajak T F et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998; 339: 1979-84.
11. Tierney J, Arnott S J, Duncan W et al. Preoperative radiotherapy for esophageal carcinoma. Cochrane Database Syst Rev 2005; 4: CD001799.
12. Cunningham D, Allum W H, Stenning S P et al. Perioperative chemotherapy in operable gastric and lower oesophageal cancer: Final results of a randomized, controlled trial. Proc Am Soc Clin Oncol 2005; #4001.
13. Macdonald J S, Smalley S R, Benedetti J et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001; 345: 725-30.
14. Denham J W, Steigler A, Kilmurray J et al. Relapse patterns after chemo-radiation for carcinoma of the esophagus. J Clin Oncol 2003; 15: 98-108.
15. Smalley S R, Gunderson L, Tepper J et al. Gastric surgical adjuvant radiotherapy consensus report: Rationale and treatment implementation. Int J Radiat Oncol Biol Phys 2002; 52: 283-93.
16. Minsky B D, Pajak T F, Ginsberg R J et al. A phase III trial of combined modality therapy for esophageal cancer: High-dose versus standard-dose radiation therapy. J Clin Oncol 2002; 20: 1167-74.
17. Bedenne L, Michel P, Bouche O et al. Randomized phase III trial in locally advanced esophageal cancer: Radiochemotherapy followed by surgery versus radiochemotherapy alone. Proc Am Soc Clin Oncol 2002; 21: 130a (abstr 519).